Agnese Latorre

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

M. De Lena, Vito Lorusso, Agnese Latorre et al. · European Journal of Cancer · 2001 · 169 citations

Medicine, Oncology, Pharmacology +14

Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of β‐tubulins

Stefania Tommasi, Anita Mangia, Rosanna Lacalamita et al. · International Journal of Cancer · 2007 · 142 citations

Medicine, Oncology, Pharmacology +14

Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer

Angelo Paradiso, Anita Mangia, Annalisa Chiriatti et al. · Annals of Oncology · 2005 · 142 citations

Medicine, Oncology, Pharmacology +16

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Sabino De Placido, Ciro Gallo, Michelino De Laurentiis et al. · The Lancet Oncology · 2018 · 88 citations · Full text

Medicine, Endocrinology, Oncology +11

Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs

Maria Colomba Comes, Annarita Fanizzi, Samantha Bove et al. · Scientific Reports · 2021 · 68 citations · Full text

Medicine, Oncology, Radiology +17